China AI drug-design deals swell as US scrutiny mounts
Global pharmaceutical firms are tapping into Chinese artificial intelligence assets before patents expire on blockbuster drugs, ...
Read the original at scmp.com ↗
- Topics
- China & GeopoliticsHealthcare
- Mentions
- China
- Tracked via
- “chinese ai”